'Skyrocketing' Drug Prices, Access And Availability In Line For EU Scrutiny

Jun 20 2016

• By Ian Schofield

Listen to this article

The European Commission is to conduct an analysis of the impact of incentives such as data exclusivity, market exclusivity and patent term extensions on innovation, drug pricing, and access to medicines, including generics. The move was requested by member state health ministers who say they are concerned about cases of 'very high and unsustainable price levels' hindering patient access to effective and affordable medicines.

The European Commission is to conduct an analysis of the impact of incentives such as data exclusivity, market exclusivity and patent term extensions on innovation, drug pricing, and access to medicines, including generics. The move was requested by member state health ministers who say they are concerned about cases of 'very high and unsustainable price levels' hindering patient access to effective and affordable medicines.

In a set of conclusions adopted on June 171, the Council of the European Union urged the member states to...

More from Archive

Test-Pharma Warming Up To Benefits Of Australia’s Teletrials Initiative
Sep 24 2024
• By Sabbah
Test
Final Chance To Have Your Say: Take Our Reader Survey This Week
Sep 16 2024
• By Nielsen Hobbs
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
Test H1 Heading
Sep 10 2024
Test H1 Story
Shape Our Content: Take The Reader Survey
Sep 04 2024
• By Nielsen Hobbs
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.

More from Pink Sheet

COVID Vaccines: US FDA Changes Course, Wants New Formulas To Target KP.2 Subvariant ‘If Feasible’
Jan 05 2026
• By Sue Sutter
Revised recommendation is based on most recent data on circulating strains in US, where KP.3 is now dominant. Novavax sticks with plans targeting the JN.1 ‘parent strain.’
Nancy Tests New Podcast Template
Dec 16 2025
• By Derrick Gingery
Pink Sheet reporter and editors discuss the US FDA’s changes to the COVID-19 vaccine indication and its revocation of the vaccine emergency use authorizations, as well as new vaccine coverage and reimbursement questions.
PinkSheet-R&D-Free: ‘Ranking’ article that includes different Composer content
Nov 20 2025
• By Nabil, Olga Zviezdicheva, Reed Miller, Mary Jo Laffler, Ian Schofield, João Andrés-Ruíz de la Fontaine-LeBlanc, Chloë Anastasía-Stojanović del Castillo-Ribeirão, and Nabil
To make your document look professionally produced, Word provides header, footer, cover page, and text box designs that complement each other. For example, you can add a matching cover page, header, and sidebar. Click Insert and then choose the elements you want from the different galleries.